Bipartisan congressional lawmakers have reintroduced a bill to set a federal marijuana research agenda and create a designation of “Centers of Excellence in Cannabis Research” for universities to carry out cannabis studies with federal grant money.
The legislation filed by Reps. Scott Peters (D-CA) and Dave Joyce (R-OH) on Friday is nearly identical to the version they filed last session—except that its title was revised to exclude a marijuana-related punny acronym, omitting the phrase “Developing and Nationalizing Key,” or DANK, from the “Cannabis Research Act.”
In any case, the measure would require the National Institutes on Health (NIH) to collaborate with other agencies, including the Centers for Disease Control and Prevention (CDC) and Substance Abuse and Mental Health Services Administration (SAMHSA) to develop “a national cannabis research agenda that addresses key questions and gaps in evidence.”
That agenda must include six primary research objectives. For example, the agencies must prioritize studies into the safety and efficacy of cannabis in the treatment of multiple conditions such as epilepsy, multiple sclerosis, chemotherapy-related pain and nausea, as well as the use of marijuana as an opioid alternative.
Other agenda items include research into the effects of cannabis on “at-risk populations” like children and
Read full article on Marijuana Moment
